Health
Australian firm says its nasal spray reduced coronavirus growth in animal study – The Tribune
Ena Respiratory ready to test INNA-051 in human trials in less than four months
Sydney, September 28
Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly reduced the growth of the coronavirus in a recent study on animals.
A study on ferrets showed the product dubbed INNA-051, which could be used complementary to vaccines, lowered the levels of the virus that causes COVID-19 by up to 96%, the company said.
The study was led by British government agency Pu…
-
General13 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General18 hours agoCone of Silence. Is secret Aussie spy in Rex Patrick case a man or a woman?
-
Noosa News22 hours agoJane Edmanson hangs up her Gardening Australia hat, reflects on labour of love behind show’s success
-
Business17 hours agoWhy this ASX 200 tech stock could rise 20%